studi
rate
antivir
activ
scutellaria
baicalensi
georgi
baicalensi
extract
influenza
viru
subtyp
exampl
pandem
season
ethyl
acet
etoac
chloroform
extract
inhibit
vitro
neuraminidas
na
enzymat
activ
viral
replic
methanol
meoh
extract
etoac
extract
demonstr
na
inhibit
ic
valu
rang
gml
plaqu
reduct
ic
valu
rang
gml
chloroform
extract
show
antivir
activ
plaqu
reduct
ic
valu
rang
gml
timeofaddit
assay
indic
etoac
chloroform
extract
also
significantli
inhibit
viru
yield
infect
hplc
analysi
demonstr
baicalin
domin
meoh
extract
baicalein
chrysin
rich
etoac
chloroform
extract
molecular
simul
reveal
baicalein
hydrogen
bond
well
hydrophob
van
der
waal
interact
activ
site
baicalein
inhibit
vitro
replic
influenza
virus
pandem
ic
season
use
plaqu
reduct
assay
combin
lowdos
baicalein
antiinfluenza
agent
could
applic
develop
altern
remedi
treat
influenza
viru
infect
influenza
viru
member
orthomyxovirida
famili
envelop
viru
contain
eight
segment
negativesens
singlestrand
rna
viral
genom
encod
protein
exampl
hemagglutinin
ha
neuraminidas
na
nonstructur
protein
np
rnp
ha
na
locat
outer
side
viral
envelop
inner
side
envelop
protein
ha
contain
receptorbind
site
respons
viru
fusion
infect
na
digest
sialic
acid
cell
surfac
result
releas
viru
particl
spread
viru
ion
channel
modul
acid
ph
endosom
allow
acidif
intern
virion
core
well
caus
releas
vrnp
cell
cytoplasm
envelop
protein
ha
na
play
key
role
viral
infect
make
prime
target
prophylaxi
therapeut
antiinfluenza
viru
drug
still
oseltamivirresist
amantadineresist
variant
emerg
identifi
sever
countri
creat
need
develop
new
antiinfluenza
compound
influenza
viru
consist
ha
na
subtyp
human
influenza
virus
subtyp
commonli
caus
acut
respiratori
diseas
avian
influenza
evidencebas
complementari
altern
medicin
virus
subtyp
occasion
infect
human
reassort
pandem
avian
swine
human
influenza
virus
caus
global
outbreak
first
human
pandem
kind
centuri
pandem
rapidli
spread
worldwid
infect
billion
peopl
april
august
viru
replic
mucos
epitheli
cell
upper
lower
airway
lung
pneumocyt
alveolar
macrophag
mucou
gland
lymph
node
caus
patholog
similar
virus
oseltamivirresist
pandem
isol
mutat
na
identifi
drugresist
pandem
variant
increas
worldwid
importantli
novel
avianorigin
influenza
viru
caus
outbreak
sever
fatal
respiratori
diseas
china
becom
global
public
health
concern
new
therapi
vaccin
influenza
infect
becom
urgent
scutellaria
baicalensi
georgi
huangqin
chines
tradit
chines
medicin
herb
exhibit
mani
biolog
activ
exampl
antipyret
antibacteri
antivir
andor
antiinflammatori
properti
extract
baicalensi
inhibit
growth
urotheli
carcinoma
cell
induc
apoptosi
human
monocyt
leukemia
osteogen
sarcoma
cell
baicalensi
extract
modul
product
cytokin
link
antivir
activ
baicalin
baicalein
wogonin
wogonin
oroxylin
oroxylin
apigenin
chrysin
major
bioactiv
compon
baicalensi
baicalin
baicalein
inhibit
viral
replic
parainfluenza
influenza
hepat
b
sar
coronaviru
wogonin
inhibit
hepat
b
surfac
antigen
secret
reduc
hbvdna
level
vitro
confirm
anim
model
infect
duck
hepat
b
viru
apigenin
also
inhibit
vitro
replic
influenza
adenovirus
laboratori
baicalensi
water
extract
show
inhibitori
effect
vitro
enzymat
activ
influenza
viru
na
studi
probe
antivir
activ
ethyl
acet
etoac
methanol
meoh
chloroform
extract
influenza
viru
subtyp
like
pandem
season
influenza
virus
addit
molecular
simul
vitro
assay
indic
flavonoid
baicalensi
baicalein
baicalin
potenti
na
inhibitori
agent
madindarbi
canin
kidney
mdck
cell
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
dilut
penicillinstreptomycin
solut
hyclon
gml
amphotericin
use
influenza
viru
amplif
plaqu
assay
thirti
gram
baicalensi
crude
powder
sun
ten
pharmaceut
co
ltd
dissolv
ml
ethyl
acet
etoac
methanol
meoh
chloroform
gentli
sonic
min
room
temperatur
extract
solut
centrifug
filter
whatman
filter
paper
lyophil
freez
dryer
iwaki
lyophil
extract
powder
kept
c
stock
solut
mgml
dissolv
phosphatebuff
salin
steril
use
syring
filter
store
c
use
baicalein
baicalin
chrysin
apigenin
purchas
sigma
chemic
co
st
loui
mo
usa
use
marker
compound
baicalensi
flavonoid
fingerprint
profil
baicalensi
extract
analyz
compar
retent
time
marker
compound
use
hitachi
hplc
system
hitachi
japan
quaternari
pump
pump
uv
detector
water
xbridg
column
mm
water
mobil
phase
perform
linearli
gradient
acetonitril
sodium
acet
water
period
min
chromatograph
separ
set
mlmin
flow
rate
elut
peak
detect
nm
peak
area
autocalcul
pda
detector
fluorometr
substrat
dnacetylneuramin
acid
munana
sigma
use
determin
na
activ
describ
prior
report
determin
na
activ
pandem
season
virus
serial
dilut
virus
pfuml
ad
well
plate
mix
munana
solut
final
concentr
incub
h
c
rel
na
enzymat
activ
determin
fluoresc
intens
nm
excit
nm
emiss
wavelength
multidetect
fluorescenceluminesc
micropl
reader
examin
inhibitori
effect
baicalensi
na
activ
serial
dilut
extract
flavonoid
preincub
subtyp
influenza
viru
pfuml
h
c
mixtur
follow
react
munana
solut
anoth
hour
concentr
extract
flavonoid
show
inhibitori
effect
ic
compar
control
inhibitor
determin
evidencebas
complementari
altern
medicin
comput
program
provid
john
spoug
nation
institut
health
mdck
cell
cultur
plate
follow
h
incub
ad
medium
contain
baicalensi
extract
gml
baicalein
baicalin
apigenin
chrysin
quintupl
well
perform
concentr
surviv
rate
cell
determin
mtt
bromid
assay
well
l
mtt
solut
mgml
ad
anoth
h
incub
wash
three
time
phosphat
buffer
salin
final
ad
l
dmso
well
dissolv
formazan
crystal
cell
surviv
rate
calcul
ratio
optic
densiti
od
nm
od
nm
treat
cell
mock
cell
data
repres
mean
sd
three
independ
experi
concentr
give
cytotox
effect
cc
determin
comput
program
develop
dr
john
spoug
nation
institut
health
activ
baicalensi
confluent
monolay
mdck
cell
plate
inocul
influenza
viru
pfu
immedi
treat
withwithout
baicalensi
extract
gml
baicalein
baicalin
apigenin
chrysin
h
absorpt
c
cell
overlaid
mainten
dmem
medium
contain
agaros
serum
albumin
gml
trypsin
day
incub
c
humidifi
atmospher
co
cell
stain
crystal
violet
formaldehyd
solut
concentr
give
plaqu
inhibit
ic
determin
use
comput
program
tabl
sybr
green
pcr
master
mix
sybr
green
dsdna
bind
dye
abi
prism
sequenc
detect
system
appli
biosystem
valu
rel
viral
rna
load
calcul
subtract
valu
viral
load
cultur
media
treat
infect
cell
valu
mockinfect
cell
valu
indic
reduct
equal
inhibitori
concentr
ic
viru
rna
load
dock
crystal
structur
neuraminidas
pdb
pdb
pdb
deposit
rcsb
protein
data
bank
http
wwwrcsborgpdb
use
target
molecular
dock
dock
calcul
baicalensi
flavonoid
tamiflu
perform
ligandfit
program
within
softwar
packag
discoveri
studio
accelri
san
diego
usa
autom
tool
ligandprotein
dock
score
prepar
protein
protocol
use
na
structur
includ
follow
action
standard
atom
name
insert
miss
atom
residu
remov
altern
conform
insert
miss
loop
region
base
seqr
data
optim
short
medium
size
loop
region
looper
algorithm
minim
remain
loop
region
calcul
pk
proton
structur
figur
realtim
rtpcr
assay
indic
simultan
postinfect
treatment
etoac
chloroform
extract
gml
caus
reduct
viru
rna
load
valu
greater
compar
mockinfect
supernat
baicalensi
contain
compound
identifi
flavonoid
six
major
bioactiv
flavonoid
baicalensi
baicalein
baicalin
wogonin
wogonsid
oroxylin
oroxylin
minor
bioactiv
flavonoid
chrysin
apigenin
forth
examin
fingerprint
baicalensi
extract
baicalein
baicalin
apigenin
chrysin
use
standard
marker
compon
three
extract
analyz
use
hplc
revers
phase
column
figur
retent
time
hlpc
chromatograph
nm
min
baicalin
min
apigenin
min
baicalein
min
chrysin
respect
hplc
chromatogram
indic
concentr
baicalin
apigenin
baicalein
chrysin
meoh
extract
figur
etoac
extract
figur
b
chloroform
extract
figur
c
respect
addit
four
maker
use
hplc
chromatogram
demonstr
compon
extract
analyz
associ
rel
concentr
flavonoid
antivir
activ
differ
extract
baicalein
baicalin
apigenin
chrysin
influenza
virus
rate
molecular
dock
na
na
enzymat
inhibit
plaqu
reduct
assay
tabl
figur
order
predict
vital
antivir
compon
baicalensi
etoac
chloroform
extract
comput
simul
baicalensi
flavonoid
baicalein
baicalin
apigenin
chrysin
influenza
virus
perform
score
model
use
two
score
function
ligscor
dockscor
addit
tamiflu
use
posit
control
dock
experi
result
show
baicalensi
flavonoid
especi
baicalin
baicalein
bond
well
high
affin
base
higher
score
valu
use
dreid
dockscor
program
tabl
shown
tabl
evidencebas
complementari
altern
medicin
interact
baicalin
show
five
hydrogen
bond
baicalin
well
van
der
waal
interact
ligand
pocket
iii
figur
b
tabl
simul
apigenin
chrysin
figur
c
hydrogen
bond
van
der
waal
interact
present
ligand
residu
pocket
iii
interact
show
baicalein
directli
interact
hydrophob
pocket
pocket
ii
form
highli
conserv
residu
na
baicalin
apigenin
chrysin
hydrogen
bond
charg
residu
pocket
iii
result
indic
four
flavonoid
directli
interact
activesit
residu
baicalein
show
uniqu
interact
particularli
via
hydrophob
interact
flavonoid
baicalein
baicalin
apigenin
chrysin
test
inhibitori
abil
na
enzymat
activ
use
fluorometr
assay
tabl
baicalein
show
therapeut
index
greater
cc
ic
plaqu
reduct
variant
interestingli
viru
yield
assay
realtim
pcr
indic
flavonoid
higher
antivir
activ
infect
simultan
treatment
figur
studi
demonstr
differ
na
enzymat
activ
influenza
subtyp
well
high
na
activ
pandem
influenza
viru
low
na
activ
season
influenza
viru
figur
correl
vitro
na
sensit
baicalensi
extract
tabl
timeofaddit
assay
reveal
etoac
chloroform
extract
reduc
viru
yield
significantli
simultan
postinfect
treatment
assay
figur
also
attest
therapeut
potenti
etoac
chloroform
extract
influenza
reveal
etoac
chloroform
extract
multipl
antiinfluenza
viru
action
except
na
inhibit
flavonoid
identifi
baicalensi
link
antivir
activ
etoac
chloroform
extract
shown
figur
retent
time
order
four
flavonoid
revers
phase
column
chrysin
min
baicalein
min
apigenin
min
baicalin
min
accord
prior
studi
meanwhil
glycosid
form
like
baicalin
wogonsid
roxylin
flavonoid
baicalensi
rich
methanol
extract
aglycon
form
baicalein
wogonin
identifi
ethyl
acet
extract
baicalein
chrysin
rich
etoac
chloroform
extract
involv
antivir
action
two
extract
influenza
evidencebas
complementari
altern
medicin
virus
vitro
antivir
assay
indic
baicalein
potent
na
inhibitor
na
inhibit
ic
less
tabl
significantli
inhibit
replic
influenza
virus
cell
cultur
plaqu
reduct
ic
less
tabl
molecular
model
initi
use
predict
interact
na
baicalensi
flavonoid
impli
correl
inhibitori
activ
baicalensi
extract
use
dreid
dockscor
elucid
molecular
interact
flavonoid
na
activ
site
hydrogen
bond
van
der
waal
lipophil
polar
attractiverepuls
interact
rank
dock
score
flavonoid
dreid
dockscor
baicalin
baicalein
apigenin
chrysin
tabl
tabl
figur
reveal
four
flavonoid
bind
na
activ
site
consist
catalyt
site
number
substrat
bind
framework
site
molecular
model
complex
show
five
hydrogen
bond
ligand
well
van
der
waal
interact
ligand
meanwhil
molecular
interact
baicalein
one
hydrogen
bond
ligand
well
hydrophob
van
der
waal
interact
ligand
differ
interact
baicalein
baicalin
could
correl
hydrophil
charact
baicalin
three
hydroxyl
group
dglucopyranosiduron
acid
compar
baicalein
reason
could
respons
correl
dock
score
antivir
activ
four
flavonoid
na
enzymat
inhibit
plaqu
reduct
assay
tabl
order
inhibitori
efficaci
antivir
activ
baicalein
baicalin
apigenin
chrysin
result
suggest
hydrophob
interact
potenti
inhibitor
highli
conserv
pocket
ii
provid
altern
approach
treat
na
inhibitorresist
mutant
mutat
four
baicalensi
associ
flavonoid
use
studi
baicalein
show
potent
antiinfluenza
viru
activ
ic
na
inhibit
valu
rang
ic
plaqu
reduct
valu
rang
tabl
baicalin
also
potent
antiinfluenza
viru
activ
ic
rang
apigenin
chrysin
display
moder
inhibitori
effect
influenza
variant
timeofaddit
assay
postinfect
treatment
flavonoid
potent
inhibitori
effect
viru
yield
compar
simultan
treatment
link
na
inhibit
activ
reduct
viru
releas
cultur
supernat
baicalein
exhibit
broad
spectrum
antivir
activ
exampl
dengu
influenza
sendai
human
cytomegaloviru
baicalein
inhibit
na
activ
influenza
sendai
virus
echo
find
na
inhibit
baicalein
pandem
influenza
viru
plu
anoth
four
variant
likewis
baicalein
suppress
product
human
monocytederiv
macrophag
asid
baicalein
baicalin
manifest
antivir
activ
influenza
sar
coronaviru
herp
simplex
viru
type
baicalein
inhibit
env
proteinmedi
fusion
chemokin
receptor
entri
process
although
literatur
survey
result
indic
baicalein
baicalin
exhibit
potent
antiinfluenza
antiinflammatori
activ
low
therapeut
index
combin
baicalein
ribavirin
demonstr
synergist
effect
inhibit
vitro
vivo
replic
influenza
viru
combin
treatment
baicaleinbaicalin
activ
agent
could
reduc
cytotox
lower
dosag
baicaleinbaicalin
prove
antiinfluenza
potenc
baicalensi
extract
contain
mani
flavonoid
exhibit
broad
spectrum
antivir
activ
process
differ
molecular
mechan
viral
infect
except
four
flavonoid
test
studi
tetrahydroxyflavon
identifi
baicalensisassoci
flavonoid
exhibit
potent
antiinfluenza
efficaci
via
inhibit
na
enzymat
activ
baicalensi
extract
suppress
hbv
core
gene
promot
activ
led
inhibit
viru
product
vitro
baicalensi
extract
also
modul
cytokin
product
human
peripher
blood
leukocyt
enhanc
resist
host
cell
vesicular
stomat
viru
infect
baicalein
wogonin
reduc
inflamm
via
suppress
activ
regul
inflamm
transcript
activ
cytokin
product
could
associ
antiinfluenza
viru
activ
baicalensi
extract
investig
detail
baicalensi
etoac
chloroform
extract
contain
high
concentr
baicalein
significantli
inhibit
vitro
na
activ
replic
influenza
viru
subtyp
includ
pandem
well
season
influenza
virus
comparison
therapeut
index
among
three
extract
type
indic
etoac
chloroform
extract
potenti
therapeut
agent
influenza
viru
among
flavonoid
baicalein
key
antivir
compon
etoac
chloroform
extract
naspecif
inhibitor
show
potent
antiinfluenza
viru
activ
yet
highli
cytotox
mdck
cell
combin
lowdos
baicalein
antivir
agent
could
altern
remedi
influenza
viru
infect
suhua
huang
cofirst
author
